Addiction Medicine · Clinical Calculator · Screening

COWS Clinical Opiate Withdrawal Scale

The Clinical Opiate Withdrawal Scale (COWS) grades the severity of acute opioid withdrawal across 11 observational items. Total score 0–48 grades severity and supports the decision to begin buprenorphine induction — a sufficient level of withdrawal (typically COWS ≥ 8 by observation) is required to avoid precipitated withdrawal.

Published: References: 3 Read time:

← All calculators & tools  ·  CIWA-Ar (alcohol withdrawal) →

Instructions
  1. Confirm a history of recent opioid use and that enough time has elapsed since the last dose for withdrawal to begin.
  2. Score each of the 11 items from direct observation and brief questioning at the bedside, using the pre-set option for each item.
  3. The total score (0–48) and severity band update automatically. Re-score every 1–4 hours when actively managing withdrawal, including during buprenorphine induction.
  4. For buprenorphine induction: give the first dose only when the patient is in sufficient withdrawal — typical threshold is COWS ≥ 8 by observation (or ≥ 12 if relying mainly on patient-reported items), to minimize the risk of precipitated withdrawal.

All computation runs in your browser; no values are stored or transmitted.

When to Use

Use the COWS in adults with a documented history of recent opioid use who are, or may be, in acute withdrawal. It grades severity, times buprenorphine induction (the patient must be in enough withdrawal before the first dose), and supports repeated reassessment during treatment of opioid use disorder.

✅

Appropriate population

Awake adults with known or suspected recent opioid use — heroin, fentanyl, oxycodone, morphine, codeine, tramadol, loperamide, or a prescribed opioid. Useful in the emergency department, inpatient wards, outpatient addiction clinics, and during supervised home-start buprenorphine induction.

⚠️

When NOT to rely on it

The COWS depends on a mix of observation and brief patient report (joint aches, anxiety, GI upset). It is not designed for alcohol, benzodiazepine, or stimulant withdrawal, is unreliable in patients who cannot communicate (intubated, obtunded), and may be confounded by acute pain, sepsis, stimulant intoxication, methadone-dominant pharmacology (very long half-life delays withdrawal onset), or concurrent sedative use. Pupillary findings can be masked by eye drops, bright lighting, or ocular disease. The scale grades severity — it does not diagnose opioid use disorder.

Pearls & Pitfalls
💡

Buprenorphine induction: wait for enough withdrawal

Buprenorphine has very high mu-opioid receptor affinity with only partial agonism — giving it to a patient still dependent on a full agonist displaces the full agonist and precipitates withdrawal. A sufficient COWS on arrival (typically ≥ 8 by observation, or ≥ 12 if relying mainly on patient-reported items; see the ASAM 2020 guideline) means receptors are free enough for buprenorphine to improve, not worsen, symptoms.

🔬

Bedside tips

Items 1 (pulse), 4 (pupil size), 8 (tremor), 9 (yawning), and 11 (gooseflesh) are the most objective — anchor assessment there and score first. Score the subjective items (bone/joint aches, anxiety, GI upset) only on what the patient actually reports. Methadone and other long-acting opioids delay withdrawal onset by 24–72 hours; fentanyl may show atypical, prolonged or recrudescent withdrawal because of extensive tissue distribution. Reassess every 1–2 hours during active induction.

🚫

Pitfalls

(1) Pupillary findings are confounded by anticholinergic or sympathomimetic eye drops, bright ambient light, and ocular disease. (2) Sympathetic overactivity from stimulants, sepsis, pain, or anxiety can mimic withdrawal and inflate the score. (3) The scale under-performs in non-communicative patients. (4) A low or falling COWS does not exclude ongoing craving or risk of relapse — pair the acute assessment with long-term management of opioid use disorder (buprenorphine, methadone, or naltrexone), harm-reduction counseling, and naloxone take-home. (5) In fentanyl-dominant settings consider low-dose or "micro-induction" strategies with specialist input; the standard COWS thresholds are an entry point, not a ceiling.

Why Use It

Opioid use disorder is undertreated, and medications for opioid use disorder — buprenorphine in particular — save lives. Starting buprenorphine safely hinges on one judgment call: is the patient in enough withdrawal that a partial agonist will help rather than precipitate it? The COWS turns a bedside impression into a reproducible 0–48 score that can be documented, handed over between shifts, and matched to protocol thresholds. The 2020 ASAM National Practice Guideline for the Treatment of Opioid Use Disorder recommends a validated withdrawal scale (COWS is the standard) to time buprenorphine induction, and the original validation study by Tompkins and colleagues (2009) confirmed the COWS performs comparably to the longer CINA opioid-withdrawal instrument against which it was anchored. The score also drives supportive pharmacotherapy — alpha-2 agonists for sympathetic overdrive, antiemetics, antidiarrheals, non-opioid analgesia — and documents treatment response over time.

COWS — Clinical Opiate Withdrawal Scale

Score each of the 11 items using the preset option that best fits the bedside finding. The total (0–48), severity band, and buprenorphine-induction readiness update automatically.

Measure after the patient sits or lies at rest for 1 minute.
Observe and ask. Exclude fever or hot environment.
Observe directly during the interview.
Confounded by eye drops, bright light, and ocular disease.
Exclude pain explained by another condition.
—
Total COWS
0–48
—
Severity Band
enter items to score
—
Bup. induction
threshold typically ≥ 8

⚕ Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253–259. The COWS grades severity and supports — but does not replace — clinical judgment about buprenorphine induction. Thresholds vary by protocol and clinical context; the ASAM 2020 guideline suggests ≥ 12 if relying on patient history and ≥ 8 if relying on observed findings. For licensed clinicians; not a substitute for individualized assessment.

Next Steps

Use the total score and the trajectory to pick symptomatic care and time buprenorphine induction.

  • Score 5–12 — mild withdrawal: offer supportive care — hydration, light meals, quiet environment — plus symptomatic agents (alpha-2 agonist, antiemetic, loperamide, non-opioid analgesia). Initiation of buprenorphine may be premature; reassess at 1–2 hour intervals.
  • Score 13–24 — moderate withdrawal: at this level most protocols meet the threshold for buprenorphine induction. Give the first dose (typically 2–4 mg sublingual buprenorphine) and reassess in approximately 1–2 hours; re-dose per protocol until comfort is achieved. Continue adjunctive symptomatic agents.
  • Score 25–36 — moderately severe withdrawal: start buprenorphine and titrate more aggressively; expect to use larger total first-day doses (typically 8–16 mg sublingual over the first day). Monitor closely for sedation and over-shooting.
  • Score above 36 — severe withdrawal: the patient is highly symptomatic; proceed with buprenorphine induction unless contraindicated and consider inpatient or observation-unit settings. Involve addiction-medicine or psychiatry support where available.
  • At every level: offer naloxone take-home and overdose education, screen for concurrent alcohol, benzodiazepine, or stimulant use, treat pain non-opioid where feasible, and document a plan for ongoing medication for opioid use disorder (buprenorphine, methadone, or naltrexone).
  • Pair the COWS with the CIWA-Ar when alcohol co-use is suspected, and use Cockcroft–Gault to check whether adjunctive medications need renal dose adjustment.
Evidence & References

Scoring

ItemRange
1. Resting pulse0–4
2. Sweating0–4
3. Restlessness0–5
4. Pupil size0–5
5. Bone or joint aches0–4
6. Runny nose or tearing0–4
7. GI upset0–5
8. Tremor0–4
9. Yawning0–4
10. Anxiety or irritability0–4
11. Gooseflesh skin0–5
Total0–48

Severity Bands

Total scoreSeverity
5–12Mild withdrawal
13–24Moderate withdrawal
25–36Moderately severe withdrawal
Above 36Severe withdrawal

Buprenorphine induction thresholds

SourceSuggested COWS threshold
Wesson & Ling (2003), common practice≥ 8 (most protocols)
ASAM National Practice Guideline (2020)≥ 12 if based on patient history; ≥ 8 if based on observation

Tompkins and colleagues (2009) demonstrated concurrent validity of the COWS and single-item indices against the longer CINA opioid-withdrawal instrument, supporting its use as the standard bedside tool.

References

  1. Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253–259. doi:10.1080/02791072.2003.10400007.
  2. Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC. Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug Alcohol Depend. 2009;105(1–2):154–159. doi:10.1016/j.drugalcdep.2009.07.001.
  3. American Society of Addiction Medicine. The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update. J Addict Med. 2020;14(2S):1–91. doi:10.1097/ADM.0000000000000633.
Important: This calculator is an educational aid for licensed clinicians and does not replace individualized assessment of a patient in opioid withdrawal. The COWS grades severity to time buprenorphine induction and symptomatic treatment; it does not diagnose opioid use disorder, and it is not validated for alcohol, benzodiazepine, or stimulant withdrawal. Pupillary findings, pulse, and sweating can be confounded by eye drops, stimulant intoxication, pain, sepsis, and concurrent medications. Always integrate the score with the clinical history, the medication list, time since the last opioid, and current institutional and ASAM guidance before deciding on induction.
References 3 sources
  1. Wesson, D. R., & Ling, W. (2003). The Clinical Opiate Withdrawal Scale (COWS). Journal of Psychoactive Drugs, 35(2), 253–259. https://doi.org/10.1080/02791072.2003.10400007
  2. Tompkins, D. A., Bigelow, G. E., Harrison, J. A., Johnson, R. E., Fudala, P. J., & Strain, E. C. (2009). Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug and Alcohol Dependence, 105(1–2), 154–159. https://doi.org/10.1016/j.drugalcdep.2009.07.001
  3. American Society of Addiction Medicine. (2020). The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 focused update. Journal of Addiction Medicine, 14(2S), 1–91. https://doi.org/10.1097/ADM.0000000000000633
Dr. W Rivero, MD

W Rivero, MD, FPCP, DPSN

Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.

· Book an Appointment →

QR code — scan to save Dr. Rivero's contact info

Scan and save

All Calculators Related Guides